Zobrazeno 1 - 10
of 262
pro vyhledávání: '"Najla A. Ali"'
Autor:
Clifford M. Csizmar, Mark Gurney, Rashmi Kanagal-Shamanna, Kelly Chien, Danielle Hammond, Terra L. Lasho, Christy M. Finke, Christopher Dean, Anuya Natu, Abhishek A. Mangaonkar, Aref Al-Kali, Naseema Gangat, Ayalew Tefferi, Hassan Alkhateeb, Guillermo Garcia-Manero, Rami S. Komrokji, Najla A. Ali, Eric Padron, Guillermo Montalban-Bravo, Mrinal M. Patnaik
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/e05b4861c6fd426a925de12843717b22
Autor:
Andrew M. Brunner, Alexander Gavralidis, Najla Al Ali, Anthony Hunter, Rami Komrokji, Amer Zeidan, David A. Sallman
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 11, Pp 1-6 (2022)
Following treatment with DNMTI therapy, patients with MDS have differences in survival according to the quality of their treatment response. In this analysis, patients who achieve CRh had similar OS compared to those meeting standard “CR” criteri
Externí odkaz:
https://doaj.org/article/383dd7c757d94ef89eb58a9a3c7829dc
Autor:
Rami S. Komrokji, Avani M. Singh, Najla Al Ali, Onyee Chan, Eric Padron, Kendra Sweet, Andrew Kuykendall, Jeffrey E. Lancet, David A. Sallman
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 11, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/19be5edb20df4d4c93db17ed5c1bec4e
Autor:
Rami S. Komrokji, Somdeb Ball, Giulia Maggioni, Erica Travaglino, Najla Al Ali, Pierre Fenaux, Uwe Platzbecker, Valeria Santini, María Díez Campelo, Torsten Haferlach, Avani Singh, Akriti Jain, Luis E. Aguirre, Sara Tinsley, Zaker Schwabkey, Onyee Chan, Zhuoer Xie, Andrew Brunner, Andrew Kuykendall, John Bennett, Rena Buckstein, Rafael Bejar, Jan Bewersdorf, Hetty Carraway, Amy Dezern, Elizabeth A. Griffiths, Stephanie Halene, Robert Paul Hasserjian, Sanam Loghavi, Olatoyosi Odenike, Mrinal Patnaik, Gail Roboz, Maximillian Stahl, Mikkael Sekeres, David Steensma, Michael Robert Savona, Justin Taylor, Mina Xu, Kendra Sweet, Jeffrey Lancet, Alan List, Eric Padron, David Sallman, Amer M. Zeidan, Matteo Giovanni Della Porta
Publikováno v:
HemaSphere, Vol 7, p e616260d (2023)
Externí odkaz:
https://doaj.org/article/b4b52b43ce5f470e85edcd6a9e189772
Autor:
Luis E. Aguirre, Akriti Jain, Somedeb Ball, Najla Al Ali, David Sallman, Andrew Kuykendall, Onyee Chan, Zhuoer Xie, Alison Walker, Kendra Sweet, Jeffrey Lancet, Eric Padron, Rami S. Komrokji
Publikováno v:
HemaSphere, Vol 7, p e6555734 (2023)
Externí odkaz:
https://doaj.org/article/05647c59b15f492f8ccd39d2f59abe80
Autor:
Nathan Radakovich, David A. Sallman, Rena Buckstein, Andrew Brunner, Amy Dezern, Sudipto Mukerjee, Rami Komrokji, Najla Al-Ali, Jacob Shreve, Yazan Rouphail, Anne Parmentier, Alexandre Mamedov, Mohammed Siddiqui, Yihong Guan, Teodora Kuzmanovic, Metis Hasipek, Babal Jha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Aziz Nazha
Publikováno v:
iScience, Vol 25, Iss 10, Pp 104931- (2022)
Summary: Hypomethylating agents (HMA) prolong survival and improve cytopenias in individuals with higher-risk myelodysplastic syndrome (MDS). Only 30-40% of patients, however, respond to HMAs, and responses may not occur for more than 6 months after
Externí odkaz:
https://doaj.org/article/2af0555cd0c8408793d44b3da7b87d0f
Autor:
Abu-Sayeef Mirza, Seongseok Yun, Najla Al Ali, Hannah Shin, Joseph Luke O’Neil, Maher Elharake, Daniel Schwartz, Katherine Robinson, Ethan Nowell, Grace Engle, Ibraahim Badat, Thomas Brimer, Amra Kuc, Ashton Sequeira, Sabbir Mirza, Dhiraj Sikaria, Jesus Diaz Vera, Noah Hackney, Sammy Abusrur, Jose Jesurajan, Jameson Kuang, Shreyans Patel, Sabrina Khalil, Sonya Bhaskar, Alexander Beard, Toaa Abuelenen, Kevin Ratnasamy, Nathan Visweshwar, Rami Komrokji, Michael Jaglal
Publikováno v:
Thrombosis Journal, Vol 17, Iss 1, Pp 1-6 (2019)
Abstract Background Although patients with acute myeloid leukemia (AML) were shown to have an increased risk of thrombosis, no thrombosis risk assessment scoring system has been developed for AML patients. The Khorana Risk Score (KRS), which has been
Externí odkaz:
https://doaj.org/article/946616b33ff840a6913dcc6fedad322e
Autor:
Sara M Tinsley-Vance, Najla Al Ali, Somedeb Ball, Luis E Aguirre, Akriti G Jain, Mohammad Omar Hussaini, Onyee Chan, Andrew Kuykendall, Kendra Sweet, Jeffrey Lancet, Eric Padron, David A Sallman, Rami S Komrokji
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:355-359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b10b4532819a08061d01ad327eaa7f6
https://doi.org/10.1016/j.clml.2023.01.007
https://doi.org/10.1016/j.clml.2023.01.007
U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes
Autor:
Rami Komrokji, Luis E. Aguirre, Najla Al Ali, Mohamad Hussaini, David Sallman, Dana Rollison, Eric Padron
Publikováno v:
Blood Advances. 7:1-8
Hemolysis is a well-recognized but poorly characterized phenomenon in a subset of patients with myelodysplastic syndromes (MDS). Its pathobiological basis seems to underpin a nonimmune etiology whose clinical significance has not been adequately char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6483da148ba02cfccb6a539365044428
https://doi.org/10.1182/bloodadvances.2022007504
https://doi.org/10.1182/bloodadvances.2022007504
Autor:
Rami Komrokji, Najla Al Ali, Onyee Chan, Kendra Sweet, Andrew Kuykendall, Jeffrey Lancet, Eric Padron, David A. Sallman
Publikováno v:
Haematologica. 108:1168-1172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41098aeda6ff63617dec052feaa0d40c
https://doi.org/10.3324/haematol.2022.281607
https://doi.org/10.3324/haematol.2022.281607